MX9709913A - Metaloconstrucciones determinadas estructuralmente y aplicaciones. - Google Patents

Metaloconstrucciones determinadas estructuralmente y aplicaciones.

Info

Publication number
MX9709913A
MX9709913A MX9709913A MX9709913A MX9709913A MX 9709913 A MX9709913 A MX 9709913A MX 9709913 A MX9709913 A MX 9709913A MX 9709913 A MX9709913 A MX 9709913A MX 9709913 A MX9709913 A MX 9709913A
Authority
MX
Mexico
Prior art keywords
metal ion
secondary structure
complexing
construct
amino acids
Prior art date
Application number
MX9709913A
Other languages
English (en)
Inventor
Shubh D Sharma
Original Assignee
Rhomed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/476,652 external-priority patent/US5891418A/en
Application filed by Rhomed Inc filed Critical Rhomed Inc
Publication of MX9709913A publication Critical patent/MX9709913A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/082—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/086—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being alphaMSH, alpha melanocyte stimulating hormone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/16—Libraries containing metal-containing organic compounds
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/14—Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Structural Engineering (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Laminated Bodies (AREA)

Abstract

Se provee una metaloconstruccion, que puede ser un péptido, para usarse como un agente biologico, terapéutico, radioterapéutico, o de formacion de imágenes diagnosticas, y para usarse en métodos de química de colecciones o combinatoria; la construccion tiene una estructura secundaria global restringida conformacionalmente obtenida por formacion de complejo con un ion de metal; las construcciones de péptido son de la formula general: R1-X-R2, en donde X es una pluralidad de aminoácidos e incluye un esqueleto formador de complejo para formar complejo con iones de metal, de modo que substancialmente todas las valencias del ion de metal están ocupadas por formacion de complejo del ion de metal con X, dando como resultado una estructura secundaria regional específica que forma parte de la estructura secundaria global; y en donde R1 y R2 incluyen cada uno de 0 a aproximadamente 20 aminoácidos, los aminoácidos se seleccionan de modo que por formacion de complejo del ion de metal con X, por lo menos una porcion de R1 o bien de R2 o de ambos tienen una estructura que forma el resto de la estructura secundaria global restringida conformacionalmente; toda la estructura secundaria global o una porcion de ella; que puede ser sicnologica o regnilogica, puede formar un ligando o imitar un dominio de funcion biologico conocido; la construccion tiene una afinidad substancialmente mayor por su blanco por marcado con un ion de metal.
MX9709913A 1995-06-07 1997-12-08 Metaloconstrucciones determinadas estructuralmente y aplicaciones. MX9709913A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/476,652 US5891418A (en) 1995-06-07 1995-06-07 Peptide-metal ion pharmaceutical constructs and applications
US08/660,697 US6027711A (en) 1995-06-07 1996-06-05 Structurally determined metallo-constructs and applications

Publications (1)

Publication Number Publication Date
MX9709913A true MX9709913A (es) 1998-08-30

Family

ID=27045238

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9709913A MX9709913A (es) 1995-06-07 1997-12-08 Metaloconstrucciones determinadas estructuralmente y aplicaciones.

Country Status (10)

Country Link
US (2) US6027711A (es)
EP (1) EP0831939A4 (es)
JP (2) JP2001518055A (es)
KR (2) KR19990022735A (es)
AU (1) AU719556B2 (es)
BR (1) BR9609400A (es)
CA (1) CA2221146A1 (es)
IL (1) IL122392A (es)
MX (1) MX9709913A (es)
WO (1) WO1996040293A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551574B2 (en) * 1995-06-07 2003-04-22 Rhomed Incorporated Tuftsin metallopeptide analogs and uses thereof
WO2000036136A1 (en) * 1998-12-14 2000-06-22 Palatin Technologies, Inc. Metallopeptide combinatorial libraries and applications
US6027711A (en) * 1995-06-07 2000-02-22 Rhomed Incorporated Structurally determined metallo-constructs and applications
US6331285B1 (en) * 1996-06-05 2001-12-18 Palatin Technologies, Inc. Structurally determined cyclic metallo-constructs and applications
GB9708265D0 (en) * 1997-04-24 1997-06-18 Nycomed Imaging As Contrast agents
US6334996B1 (en) 1997-12-24 2002-01-01 Resolution Pharmaceuticals Inc. Chelators that predominantely form a single stereoisomeric species upon coordination to a metal center
AU1865899A (en) * 1997-12-24 1999-07-19 Resolution Pharmaceuticals Inc. Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center
US20020155576A1 (en) * 1998-02-10 2002-10-24 Mills Stanley L. Metal-chelated nucleic acid binding peptides for in vivo detection and therapy of disease
AU5142899A (en) * 1999-02-17 2000-09-04 Resolution Pharmaceuticals Inc. Immobilized labeling compounds and methods
WO2001013112A1 (en) * 1999-08-12 2001-02-22 Palatin Technologies, Inc. Melanocortin metallopeptide constructs, combinatorial libraries and applications
US7049398B1 (en) * 1999-08-12 2006-05-23 Palatin Technologies, Inc. Melanocortin metallopeptide constructs, combinatorial libraries and applications
WO2001036006A1 (en) * 1999-11-19 2001-05-25 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
EP1242824A2 (en) * 1999-12-30 2002-09-25 7TM Pharma Screening using biological target molecules with metal-ion binding sites
US7351690B2 (en) * 2000-12-19 2008-04-01 Palatin Technologies, Inc. Knockout identification of target-specific sites in peptides
US20050014193A1 (en) * 2003-06-17 2005-01-20 Sharma Shubh D. Identification of target-specific folding sites in peptides and proteins
ATE385811T1 (de) * 2000-12-19 2008-03-15 Palatin Technologies Inc Identifizierung zielgerichteter faltungsstellen in peptiden und proteinen
DE10064896A1 (de) * 2000-12-23 2002-07-11 Robert Tampe Schaltbare biochemische Pinzetten und synthetische Rezeptoren zur molekularen Organisation und Manipulation von Biomolekülen
WO2002054077A2 (en) * 2000-12-29 2002-07-11 7Tm Pharma A/S Validating biological molecules as drug targets by metal-ion chelates in animal test models
AU2002238106A1 (en) * 2001-02-13 2002-08-28 Palatin Technologies, Inc. Melanocortin metallopeptides for treatment of sexual dysfunction
AU2002331064B2 (en) * 2001-08-10 2007-08-23 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7732451B2 (en) * 2001-08-10 2010-06-08 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule
US7456184B2 (en) * 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
US7718802B2 (en) 2001-08-10 2010-05-18 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
US7655658B2 (en) * 2001-08-10 2010-02-02 Palatin Technologies, Inc. Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
US20040106548A1 (en) * 2001-09-07 2004-06-03 Schmidt Michelle A Conformationally constrained labeled peptides for imaging and therapy
US6873883B2 (en) * 2001-12-26 2005-03-29 Hewlett-Packard Development Company, L.P. Adaptive fan controller for a computer system
EP1488011A4 (en) * 2002-03-13 2006-04-05 New Century Pharmaceuticals METHOD OF ISOLATING BINDING PEPTIDES FROM A COMBINATORIC PHAG DISPLAY LIBRARY AND PEPTIDES PRODUCED THEREFOR
US7968548B2 (en) * 2003-05-01 2011-06-28 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine compounds with diamine groups
US7727990B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine and keto-piperazine compounds
US7727991B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Substituted melanocortin receptor-specific single acyl piperazine compounds
US20050143919A1 (en) * 2003-11-14 2005-06-30 Williams Robert E. Unified method and system for multi-dimensional mapping of spatial-energy relationships among micro and macro-events in the universe
US7709484B1 (en) 2004-04-19 2010-05-04 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
ITRM20040239A1 (it) * 2004-05-13 2004-08-13 Sigma Tau Ind Farmaceuti Derivati ciclopeptidici ad attivita' antintegrine.
ATE534664T1 (de) 2004-05-24 2011-12-15 Inst Cardiologie Montreal Markierte adrenomedullinderivate und deren verwendung zur bilddarstellung und therapie
US20070270591A1 (en) * 2006-05-16 2007-11-22 Ashmead H Dewayne Iron (II) amino acid chelates with reducing agents attached thereto
KR100755746B1 (ko) * 2006-05-22 2007-09-06 한국과학기술원 중금속 흡착 단백질을 이용한 양자점의 제조방법 및 이를 위한 양자점 생성능을 가지는 재조합 미생물
US7834017B2 (en) 2006-08-11 2010-11-16 Palatin Technologies, Inc. Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
US20080269065A1 (en) * 2007-04-30 2008-10-30 Syntrix Biosystems, Inc. Conformationally Constrained Analytical Probes
DK2155781T3 (da) * 2007-05-11 2013-06-17 Inst Cardiologie Montreal Mærkede adrenomedullinderivater og deres anvendelse til visualisering og terapi
US20090004119A1 (en) * 2007-06-27 2009-01-01 Ge Healthcare As Polymers
CN101809028B (zh) * 2007-07-05 2015-11-25 日产化学工业株式会社 新型脂质肽和水凝胶
MX339762B (es) * 2011-09-28 2016-05-27 Univ Autonoma Del Estado De Morelos Metalopeptidos inmunomoduladores (immp) y composiciones que los contienen.

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
US6780613B1 (en) * 1988-10-28 2004-08-24 Genentech, Inc. Growth hormone variants
US5196510A (en) * 1988-12-29 1993-03-23 Cytogen Corporation Molecular recognition units
US5395609A (en) * 1989-06-19 1995-03-07 Antisoma Limited Synthetic peptides for use in tumor detection
US5700444A (en) * 1992-02-20 1997-12-23 Rhomed Incorporated Chemotactic peptide pharmaceutical applications
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
DK0486622T3 (da) * 1989-08-09 1999-07-19 Rhomed Inc Direkte radiomærkning af antistoffer og andre proteiner med technetium eller rhenium
US5382654A (en) * 1992-02-05 1995-01-17 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
US5475085A (en) * 1991-02-07 1995-12-12 Molecumetics, Ltd. Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging
ATE197767T1 (de) * 1992-01-03 2000-12-15 Rhomed Inc Pharmazeutische anwendungen auf der basis von peptid-metall-ionen
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
US5464934A (en) * 1993-05-14 1995-11-07 Mallinckrodt Medical, Inc. Metal chelates as spacer compounds in biologically active peptides
ES2114209T3 (es) * 1993-07-19 1998-05-16 Resolution Pharm Inc Queladores de radionuclidos de tipo hidrazino que tienen una configuracion n3s.
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
US5480970A (en) * 1993-12-22 1996-01-02 Resolution Pharmaceuticals Metal chelators
US5569745A (en) * 1994-02-25 1996-10-29 Resolution Pharmaceuticals Inc. Peptide-Chelator conjugates
US5662885A (en) * 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
US6027711A (en) * 1995-06-07 2000-02-22 Rhomed Incorporated Structurally determined metallo-constructs and applications
US5891418A (en) * 1995-06-07 1999-04-06 Rhomed Incorporated Peptide-metal ion pharmaceutical constructs and applications
US6331285B1 (en) * 1996-06-05 2001-12-18 Palatin Technologies, Inc. Structurally determined cyclic metallo-constructs and applications
DE69738353T2 (de) * 1996-07-12 2009-09-24 Immunomedics, Inc. Radiometall-bindende peptide analoge
GB9624927D0 (en) * 1996-11-29 1997-01-15 Oxford Glycosciences Uk Ltd Gels and their use
US6083758A (en) * 1997-04-09 2000-07-04 California Institute Of Technology Method for screening peptides for metal coordinating properties and fluorescent chemosensors derived therefrom
US6226603B1 (en) * 1997-06-02 2001-05-01 The Johns Hopkins University Method for the prediction of binding targets and the design of ligands
US7351690B2 (en) * 2000-12-19 2008-04-01 Palatin Technologies, Inc. Knockout identification of target-specific sites in peptides

Also Published As

Publication number Publication date
US20060040324A1 (en) 2006-02-23
JP2007056029A (ja) 2007-03-08
IL122392A (en) 2002-11-10
WO1996040293A1 (en) 1996-12-19
KR19990022735A (ko) 1999-03-25
KR20050062639A (ko) 2005-06-23
CA2221146A1 (en) 1996-12-19
EP0831939A1 (en) 1998-04-01
IL122392A0 (en) 1998-06-15
EP0831939A4 (en) 2004-11-24
AU6330096A (en) 1996-12-30
AU719556B2 (en) 2000-05-11
US6027711A (en) 2000-02-22
BR9609400A (pt) 1999-12-14
JP2001518055A (ja) 2001-10-09

Similar Documents

Publication Publication Date Title
MX9709913A (es) Metaloconstrucciones determinadas estructuralmente y aplicaciones.
FI925986A (fi) Slumpartat bio-oligomer bibliotek, ett foerfarande foer syntetisering avdet samt ett foerfarande foer anvaendning av det
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
HK1027820A1 (en) Molecules that home to a selected organ or tissue in vivo
ATE203025T1 (de) Reverse-turnmimetika und damit zusammenhängendes verfahren
GR3025596T3 (en) Compositions and methods for identifying biologically active molecules.
DK0784683T3 (da) TIE-2-ligander, fremgangsmåder til dannelse af disse og anvendelser deraf
NZ510977A (en) Novel G protein-coupled receptor proteins, DNAs thereof and ligands to the same
WO1997026277A3 (en) Morphogen analogs and methods for producing them
IL131655A0 (en) Isolation of tissue specific ligands and their use for targeting pharmaceuticals to organs
IT1299175B1 (it) Composizione contenente radioisotopi immobilizzati su particelle solide, utile in particolare per la brachiterapia clinica in patologie
DE69025194D1 (de) Aminosäure-beta-lyase-enzyminhibitoren als deodorantien
WO2001064877A3 (en) Human schizophrenia gene
ATE417930T1 (de) Proteinkinase npk-110
HK1025793A1 (en) Hepatitis c receptor protein cd81
DK0830604T3 (da) Anvendelser af apoptin
WO2001064876A3 (en) Human schizophrenia gene
IT1261386B (it) Peptidi modificati con gruppo fosfinico per la marcatura con 99m-tc e 186-188-re o agenti paramagnetici.
AU5327198A (en) Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
ATE175977T1 (de) Peptide mit affinitaet zu tumoren und diese enthaltende radioaktive diagnostische und therapeutische zusammensetzungen
AU2347501A (en) Trp-protein-related mtr1 protein and dna sequence coding therefor
NO970140L (no) Technetium-sulfonamidkomplekser, deres anvendelse, farmasöytiske midler inneholdende disse, samt fremgangsmåte for fremstilling av kompleksene og midlene
AU7353400A (en) Macrocyclic chelants for metallopharmaceuticals
GR1002903B (el) Πεπτιδιο συγγενες με ογκο και ραδιενεργος διαγνωστικος παραγοντας και ραδιενεργος θεραπευτικος παραγοντας που περιεχει το πεπτιδιο.
Scott Cytochrome c synthesis in Neurospora crassa

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees